floxacillin has been researched along with Critical Illness in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Brüggemann, RJ; Burger, DM; de Lange, DW; de Maat, MM; Frenzel, T; Gieling, EM; Kolwijck, E; Pickkers, P; Schouten, JA; Ten Oever, J; Ter Heine, R; van Leeuwen, H; Wallenburg, E | 1 |
| Foudraine, NA; Janssen, PKC; le Noble, JLML; Meenks, SD; Neef, K; Punt, N | 1 |
| Brüggemann, RJM; Jager, NGL; Lipman, J; Roberts, JA; Ulldemolins, M; van Hest, RM; Wong, G; Xie, J | 1 |
| Bassetti, S; Dräger, S; Guertler, N; Hinic, V; Moser, S; Osthoff, M; Rehm, S; Rentsch, KM; Sendi, P | 1 |
| Brüggemann, RJM; Chin, PKL; Jager, NGL; Roberts, JA; Schouten, J; Ter Heine, R; Ulldemolins, M; Wallenburg, E; Wilkes, S | 1 |
| Abdul-Aziz, MH; Lipman, J; McDonald, C; McWhinney, B; Roberts, JA; Ungerer, JP | 1 |
| Lipman, J; Rello, J; Roberts, JA; Ulldemolins, M; Wallis, SC | 1 |
1 review(s) available for floxacillin and Critical Illness
| Article | Year |
|---|---|
A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients.
Topics: Anti-Bacterial Agents; Critical Illness; Floxacillin; Healthy Volunteers; Humans; Protein Binding | 2022 |
6 other study(ies) available for floxacillin and Critical Illness
| Article | Year |
|---|---|
High unbound flucloxacillin fraction in critically ill patients.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Floxacillin; Humans; Microbial Sensitivity Tests; Monte Carlo Method | 2021 |
Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study.
Topics: Adult; Continuous Renal Replacement Therapy; Critical Illness; Floxacillin; Humans; Liver Cirrhosis; Microbial Sensitivity Tests | 2023 |
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Floxacillin; Humans; Microbial Sensitivity Tests; Monte Carlo Method | 2020 |
Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs.
Topics: Anti-Bacterial Agents; Critical Illness; Floxacillin; Humans; Microbial Sensitivity Tests; Pharmaceutical Preparations; Probability; Prospective Studies; Sepsis; Staphylococcus aureus | 2021 |
Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU.
Topics: Adult; Anti-Bacterial Agents; Central Nervous System Bacterial Infections; Critical Illness; Drug Monitoring; Floxacillin; Humans; Infusions, Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Female; Floxacillin; Humans; Hypoalbuminemia; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Plasma; Time Factors; Urine | 2010 |